Open Access Highly Accessed Research article

Effects of diet type and supplementation of glucosamine, chondroitin, and MSM on body composition, functional status, and markers of health in women with knee osteoarthritis initiating a resistance-based exercise and weight loss program

Teresa Magrans-Courtney3, Colin Wilborn2, Christopher Rasmussen1, Maria Ferreira4, Lori Greenwood1, Bill Campbell5, Chad M Kerksick6, Erica Nassar7, Rui Li8, Mike Iosia9, Matt Cooke10, Kristin Dugan2, Darryn Willoughby3, LuAnn Soliah11 and Richard B Kreider1*

Author Affiliations

1 Exercise & Sport Nutrition Lab, Department of Health & Kinesiology, Texas A&M University, College Station, TX 77843-4243, USA

2 Human Performance Lab, Exercise & Sport Science Department, University of Mary-Hardin Baylor, Belton, Texas 76513, USA

3 Department of Health, Human Performance and Recreation, Baylor University, One Bear Place, Box 97313, Waco, TX 76798-7313, USA

4 Higuchi Biosciences Center, University of Kansas, Lawrence, KS 66047, USA

5 School of Physical Education & Exercise Science, University of South Florida, Tampa, FL 33620, USA

6 Department of Health and Exercise Science, University of Oklahoma, Norman OK 73019, USA

7 Quality Improvement Programs, BlueCross and BlueShield of Texas, Dallas, TX 75266, USA

8 Bouve College of Health, Northeastern University, Boston, MA 02115, USA

9 Department of Health, Exercise Science, and Secondary Education, Lee University, Cleveland, TN 37320 m USA

10 Schools of Biomedical & Health Sciences, Victoria University, Victoria University, Melbourne Victoria 8001, Australia

11 Department of Family & Consumer Sciences, Baylor University, One Bear Place, Box 97346, Waco, TX 76798-73346, USA

For all author emails, please log on.

Journal of the International Society of Sports Nutrition 2011, 8:8  doi:10.1186/1550-2783-8-8

Published: 20 June 2011

Abstract

Background

The purpose of this study was to determine whether sedentary obese women with knee OA initiating an exercise and weight loss program may experience more beneficial changes in body composition, functional capacity, and/or markers of health following a higher protein diet compared to a higher carbohydrate diet with or without GCM supplementation.

Methods

Thirty sedentary women (54 ± 9 yrs, 163 ± 6 cm, 88.6 ± 13 kg, 46.1 ± 3% fat, 33.3 ± 5 kg/m2) with clinically diagnosed knee OA participated in a 14-week exercise and weight loss program. Participants followed an isoenergenic low fat higher carbohydrate (HC) or higher protein (HP) diet while participating in a supervised 30-minute circuit resistance-training program three times per week for 14-weeks. In a randomized and double blind manner, participants ingested supplements containing 1,500 mg/d of glucosamine (as d-glucosamine HCL), 1,200 mg/d of chondroitin sulfate (from chondroitin sulfate sodium), and 900 mg/d of methylsulfonylmethane or a placebo. At 0, 10, and 14-weeks, participants completed a battery of assessments. Data were analyzed by MANOVA with repeated measures.

Results

Participants in both groups experienced significant reductions in body mass (-2.4 ± 3%), fat mass (-6.0 ± 6%), and body fat (-3.5 ± 4%) with no significant changes in fat free mass or resting energy expenditure. Perception of knee pain (-49 ± 39%) and knee stiffness (-42 ± 37%) was decreased while maximal strength (12%), muscular endurance (20%), balance indices (7% to 20%), lipid levels (-8% to -12%), homeostasis model assessment for estimating insulin resistance (-17%), leptin (-30%), and measures of physical functioning (59%), vitality (120%), and social function (66%) were improved in both groups with no differences among groups. Functional aerobic capacity was increased to a greater degree for those in the HP and GCM groups while there were some trends suggesting that supplementation affected perceptions of knee pain (p < 0.08).

Conclusions

Circuit style resistance-training and weight loss improved functional capacity in women with knee OA. The type of diet and dietary supplementation of GCM provided marginal additive benefits.

Trial Registration

ClinicalTrials.gov: NCT01271218